SCHEMBL17592802

SCHEMBL17592802

CCC1(Cc2ccccc2)C(=O)OCOC1=O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ELANE P08246 6/20 0.51
NPSR1 Q6W5P4 2/20 0.44
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP8 P22894 2/20 0.40
MMP13 P45452 2/20 0.40
LMNA P02545 2/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD11B1 P28845 1/20 0.36
TP53 P04637 1/20 0.35
HTR7 P34969 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6380088 0.89 MAOA (0.42) ELANENPSR1MMP2MMP9MMP8
SCHEMBL17468379 0.82 ELANE (0.41) ELANENPSR1MMP2MMP9MMP8
SCHEMBL17593127 0.80 ELANE (0.50) ELANENPSR1LMNAMAOAMAOB
SCHEMBL16175012 0.79 ELANE (0.51) ELANENPSR1MMP2MMP9MMP8
SCHEMBL16174837 0.79 ELANE (0.51) ELANENPSR1MMP2MMP9MMP8
SCHEMBL287441 0.78 LMNA (0.39) ELANELMNA
SCHEMBL16174946 0.77 ELANE (0.50) ELANENPSR1MMP2MMP9MMP8
SCHEMBL16174789 0.77 ELANE (0.46) ELANENPSR1MMP2MMP9MMP8
SCHEMBL17550614 0.76 ELANE (0.40) ELANELMNAHSD11B1HTR7
SCHEMBL16174809 0.73 ELANE (0.49) ELANENPSR1MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3786199-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2021-03-03 EP claimed
CN-107075037-B Polymer comprising one or more 1, 1-disubstituted alkene compounds and polymer compositions thereof 赛鲁斯股份有限公司 2021-02-09 CN claimed
EP-3191533-B1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS INC (US) 2020-11-04 EP claimed
US-10308802-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof SIRRUS, INC. (US) 2019-06-04 US claimed
US-20170275446-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2017-09-28 US claimed
EP-3191533-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2017-07-19 EP claimed
WO-2016040261-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS, INC. (US) 2016-03-17 WO claimed
US-11021617-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof SIRRUS, INC. (US) 2021-06-01 US disclosed
EP-3786199-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2021-03-03 EP disclosed
EP-3774715-A1 HETEROGENEOUS CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS Sirrus, Inc. (US) 2021-02-17 EP disclosed
CN-107075037-B Polymer comprising one or more 1, 1-disubstituted alkene compounds and polymer compositions thereof 赛鲁斯股份有限公司 2021-02-09 CN disclosed
EP-3191533-B1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS INC (US) 2020-11-04 EP disclosed
WO-2019195366-A1 HETEROGENEOUS CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS SIRRUS, INC. (US) 2019-10-10 WO disclosed
US-20170275446-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2017-09-28 US disclosed
EP-3191533-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2017-07-19 EP disclosed
US-9416091-B1 Catalytic transesterification of ester compounds with groups reactive under transesterification conditions SIRRUS, INC. (US) 2016-08-16 US disclosed
WO-2016126624-A1 CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS SIRRUS, INC. (US) 2016-08-11 WO disclosed
US-20160229786-A1 CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS NIPPON SHOKUBAI CO., LTD. (JP) 2016-08-11 US disclosed
US-20160221922-A1 CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS SIRRUS, INC. 2016-08-04 US disclosed
WO-2016040261-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS, INC. (US) 2016-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10308802-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof PCBP1, PARG, PARP1 ELANE 2503/4885NPSR1 2445/4885MMP2 4856/4885
US-20160229786-A1 CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS NOTUM, CES1, CYP4F11 ELANE 329/4885NPSR1 3753/4885MMP2 1822/4885
US-20170275446-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF PCBP1, PARG, PARP1 ELANE 2503/4885NPSR1 2445/4885MMP2 4856/4885
US-20160221922-A1 CATALYTIC TRANSESTERIFICATION OF ESTER COMPOUNDS WITH GROUPS REACTIVE UNDER TRANSESTERIFICATION CONDITIONS NOTUM, CES1, CYP4F11 ELANE 329/4885NPSR1 3753/4885MMP2 1822/4885
US-11021617-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof PCBP1, PARG, PARP1 ELANE 2481/4885NPSR1 2559/4885MMP2 4844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.